Ampio Pharmaceuticals Inc (NYSEAMERICAN:AMPE) shares gapped up prior to trading on Thursday . The stock had previously closed at $3.22, but opened at $3.33. Ampio Pharmaceuticals shares last traded at $3.62, with a volume of 2323500 shares changing hands.

Separately, ValuEngine upgraded shares of Ampio Pharmaceuticals from a “strong sell” rating to a “sell” rating in a research report on Wednesday, October 11th.

The firm has a market capitalization of $276.69, a PE ratio of -20.35 and a beta of 0.58.

WARNING: This piece was originally published by Watch List News and is owned by of Watch List News. If you are accessing this piece on another site, it was illegally stolen and republished in violation of U.S. and international trademark and copyright legislation. The correct version of this piece can be read at

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc is a biopharmaceutical company. The Company is focused primarily on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options. The Company’s two lead product candidates in development are Ampion for osteoarthritis of the knee and Optina for diabetic macular edema.

Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with Analyst Ratings Network's FREE daily email newsletter.